The effect of Dantrium on spasticity in multiple sclerosis.
D000284:Administration, Oral; D000328:Adult; D003620:Dantrolene / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D003864:Depression, Chemical; D004576:Electromyography; D005260:Female; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009128:Muscle Spasticity / Q000188:drug therapy*; D009470:Muscle Spindles / Q000187:drug effects; D009433:Neural Inhibition / Q000187:drug effects
D006827:Hydantoins; D009125:Muscle Relaxants, Central; D003620:Dantrolene